REZATOMIDINE
UNII W5LMZ0RC8I

Substance Identification & Data

This profile provides standardized clinical and technical data for Rezatomidine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W5LMZ0RC8I.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 847829-38-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

W5LMZ0RC8I

CAS Registry Number

847829-38-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

REZATOMIDINE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C13H16N2S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WQXVKEDUCPMRRI-JTQLQIEISA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C152207

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

11287722

Unique identification number in the NCBI database of chemical substances.

INN ID

9024

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

SS-58

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1([nH]c(c[nH]1)[C@@H](C)c2c(c(ccc2)C)C)=S

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rezatomidine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.